PWMG
AZN icon

Prestige Wealth Management Group’s AstraZeneca AZN Stock Holding History

Prestige Wealth Management Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88
Closed -$16.2K – 1124
2025
Q4 		$16.2K Hold
88
– – ﹤0.01% 373
2025
Q3 		$13.5K Hold
88
– – ﹤0.01% 404
2025
Q2 		$12.3K Hold
88
– – ﹤0.01% 407
2025
Q1 		$12.9K Hold
88
– – ﹤0.01% 404
2024
Q4 		$11.5K Sell
88
-11
-11% -$1.54K ﹤0.01% 437
2024
Q3 		$15.3K Sell
99
-6
-6% -$969 ﹤0.01% 383
2024
Q2 		$16.3K Sell
105
-3
-3% -$451 ﹤0.01% 340
2024
Q1 		$14.6K Buy
108
+12
+13% +$1.59K ﹤0.01% 389
2023
Q4 		$12.9K Hold
96
– – ﹤0.01% 402
2023
Q3 		$13K Hold
96
– – ﹤0.01% 398
2023
Q2 		$13.7K Hold
96
– – ﹤0.01% 411
2023
Q1 		$13.3K Buy
96
+14
+17% +$1.88K ﹤0.01% 390
2022
Q4 		$11.1K Sell
82
-26
-24% -$3.26K ﹤0.01% 442
2022
Q3 		$12K Sell
108
-27
-20% -$3.42K ﹤0.01% 385
2022
Q2 		$18K Hold
135
– – ﹤0.01% 343
2022
Q1 		$18K Sell
135
-2
-1% -$240 ﹤0.01% 363
2021
Q4 		$16K Sell
137
-1
-0.7% -$118 ﹤0.01% 405
2021
Q3 		$17K Buy
138
+13
+10% +$1.51K ﹤0.01% 393
2021
Q2 		$15K Hold
125
– – ﹤0.01% 395
2021
Q1 		$12K Sell
125
-30
-19% -$3.02K ﹤0.01% 438
2020
Q4 		$15K Sell
155
-63
-29% -$6.67K ﹤0.01% 391
2020
Q3 		$24K Hold
218
– – 0.01% 324
2020
Q2 		$23K Sell
218
-14
-6% -$1.45K 0.01% 306
2020
Q1 		$20K Buy
232
+227
+4,540% +$21.4K 0.01% 276
2019
Q4 		$0 Hold
5
– – ﹤0.01% 575
2019
Q3 		$0 Buy
+5
New +$434 ﹤0.01% 592
2019
Q1 		– Sell
-195
Closed -$15K – 553
2018
Q4 		$15K Buy
+195
New +$15.2K 0.01% 361

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Prestige Wealth Management Group's AZN Position: Q1 2026 in Review

Prestige Wealth Management Group sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 88 shares — an estimated $16.2K sold.

Prestige Wealth Management Group first reported a position in AZN in Q4 2018 and held it in 27 quarters. The position peaked at $24K in Q3 2020. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Prestige Wealth Management Group reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Prestige Wealth Management Group sold 88 AstraZeneca shares in Q1 2026, an estimated $16.2K.
  • Prestige Wealth Management Group first reported a position in AstraZeneca in Q4 2018 and held it in 27 quarters.
  • Prestige Wealth Management Group's AstraZeneca position peaked at $24K in Q3 2020.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.